Corient Private Wealth LLC Raises Stock Position in Nutrien Ltd. (NYSE:NTR)

Corient Private Wealth LLC raised its stake in shares of Nutrien Ltd. (NYSE:NTR) by 22.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 33,254 shares of the company’s stock after buying an additional 6,027 shares during the period. Corient Private Wealth LLC’s holdings in Nutrien were worth $1,489,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in NTR. Goodman Financial Corp increased its position in Nutrien by 4.6% during the third quarter. Goodman Financial Corp now owns 253,860 shares of the company’s stock valued at $12,201,000 after acquiring an additional 11,058 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Nutrien by 10.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,742,351 shares of the company’s stock valued at $83,812,000 after purchasing an additional 157,932 shares during the period. Covea Finance increased its position in shares of Nutrien by 21.9% during the 4th quarter. Covea Finance now owns 55,600 shares of the company’s stock valued at $2,485,000 after purchasing an additional 10,000 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Nutrien by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 1,396,887 shares of the company’s stock worth $67,200,000 after purchasing an additional 151,596 shares during the period. Finally, Van ECK Associates Corp boosted its holdings in shares of Nutrien by 5.7% in the fourth quarter. Van ECK Associates Corp now owns 1,480,870 shares of the company’s stock worth $66,264,000 after buying an additional 80,382 shares during the last quarter. 63.10% of the stock is currently owned by hedge funds and other institutional investors.

Nutrien Trading Down 4.5 %

Shares of Nutrien stock opened at $50.19 on Wednesday. Nutrien Ltd. has a twelve month low of $43.70 and a twelve month high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The business has a 50-day moving average price of $51.67 and a 200-day moving average price of $48.91. The firm has a market cap of $24.56 billion, a price-to-earnings ratio of 36.64, a PEG ratio of 1.19 and a beta of 0.81.

Nutrien (NYSE:NTR) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.09). The firm had revenue of $5.08 billion for the quarter, compared to analysts’ expectations of $5.09 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. Equities research analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 4.34%. The ex-dividend date is Monday, March 31st. Nutrien’s payout ratio is 159.12%.

Wall Street Analyst Weigh In

Several research firms have weighed in on NTR. Wells Fargo & Company increased their price target on shares of Nutrien from $53.00 to $56.00 and gave the stock an “equal weight” rating in a research report on Friday, February 21st. The Goldman Sachs Group began coverage on Nutrien in a research report on Thursday, March 13th. They set a “sell” rating and a $53.00 target price on the stock. UBS Group upped their price target on Nutrien from $53.00 to $54.00 and gave the stock a “neutral” rating in a research report on Thursday, February 20th. JPMorgan Chase & Co. raised Nutrien from an “underweight” rating to a “neutral” rating and raised their price objective for the stock from $40.00 to $50.00 in a research note on Monday, January 13th. Finally, Barclays boosted their price objective on Nutrien from $56.00 to $59.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $60.13.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.